These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11965261)

  • 41. Feline immunodeficiency virus: a concise review.
    Kanzaki LI; Looney DJ
    Front Biosci; 2004 Jan; 9():370-7. PubMed ID: 14766374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination.
    J Am Vet Med Assoc; 1991 Nov; 199(10):1273-7. PubMed ID: 1666068
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease.
    Reubel GH; George JW; Higgins J; Pedersen NC
    Vet Microbiol; 1994 Apr; 39(3-4):335-51. PubMed ID: 8042279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
    Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
    AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
    Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
    Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.
    Matteucci D; Poli A; Mazzetti P; Sozzi S; Bonci F; Isola P; Zaccaro L; Giannecchini S; Calandrella M; Pistello M; Specter S; Bendinelli M
    J Virol; 2000 Dec; 74(23):10911-9. PubMed ID: 11069985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Client handout--Feline upper airway infections.
    Compend Contin Educ Vet; 2010 Jan; 32(1):12/09. PubMed ID: 23710520
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccination with feline immunodeficiency virus induces CD4 epitope masking by soluble factors.
    Leutenegger CM; Holznagel E; Hofmann-Lehmann R; Aubert A; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 2000 Mar; 73(3-4):343-52. PubMed ID: 10713346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination against feline immunodeficiency virus using fixed infected cells.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
    Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
    Westman ME; Malik R; Norris JM
    Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Backward bifurcation and oscillations in a nested immuno-eco-epidemiological model.
    Barfield M; Martcheva M; Tuncer N; Holt RD
    J Biol Dyn; 2018 Dec; 12(1):51-88. PubMed ID: 29166833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The critical vaccination fraction for heterogeneous epidemic models.
    Hill AN; Longini IM
    Math Biosci; 2003 Jan; 181(1):85-106. PubMed ID: 12421553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Animal models for the study of human immunodeficiency virus infections.
    Letvin NL
    Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of a feline panleukopenia modified live virus vaccine in cats in the primary-stage of feline immunodeficiency virus infection.
    Buonavoglia C; Marsilio F; Tempesta M; Buonavoglia D; Tiscar PG; Cavalli A; Compagnucci M
    Zentralbl Veterinarmed B; 1993 Jul; 40(5):343-6. PubMed ID: 8237206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain.
    Kohmoto M; Uetsuka K; Ikeda Y; Inoshima Y; Shimojima M; Sato E; Inada G; Toyosaki T; Miyazawa T; Doi K; Mikami T
    J Vet Med Sci; 1998 Mar; 60(3):315-21. PubMed ID: 9560779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A time since recovery model with varying rates of loss of immunity.
    Bhattacharya S; Adler FR
    Bull Math Biol; 2012 Dec; 74(12):2810-9. PubMed ID: 23097124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cat transgenesis and feline versus human AIDS.
    Di Guardo G
    Vet Pathol; 2012 Sep; 49(5):882-3. PubMed ID: 22573577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.